CenExel Creates Clinical Sciences Business Unit
Salt Lake City, Utah, Nov. 15, 2022 (GLOBE NEWSWIRE) -- CenExel announces a new Clinical Sciences business unit, composed of early phase and translational medicine scientists, plus the broader network of CenExel therapeutic experts and key opinion leaders (KOLs), providing support to all the CenExel Centers of Excellence as well as standalone consulting services.
- Salt Lake City, Utah, Nov. 15, 2022 (GLOBE NEWSWIRE) -- CenExel announces a new Clinical Sciences business unit, composed of early phase and translational medicine scientists, plus the broader network of CenExel therapeutic experts and key opinion leaders (KOLs), providing support to all the CenExel Centers of Excellence as well as standalone consulting services.
- Clinical Sciences by CenExel (Clinical Sciences) offers a unique opportunity for collaboration with pharmaceutical sponsors, CROs, and vendors, to support study development and conduct within the Sponsors clinical development program across the development lifecycle.
- All told, these elements combine in Clinical Sciences to create a unique, first-of-its-kind, holistic approach in the clinical research industry.
- Clinical Sciences by CenExel offers unprecedented expertise and experience in study design strategies including complex biomarker studies that can inform key go/no-go decisions.